Suchergebnisse - "Anti-c5 monoclonal antibody"

PubPharm (14)

1

Comparison of outcomes after plasma therapy or eculizumab in pediatric patients with atypical hemolytic uremic syndrome

enthalten in: Clinical and experimental nephrology | 2023

von Ashida, A. | Matsumura, H. | Shimono, A. | +2

2

Comparison of outcomes after plasma therapy or eculizumab in pediatric patients with atypical hemolytic uremic syndrome

enthalten in: Clinical and experimental nephrology | 2022

von Ashida, A. | Matsumura, H. | Shimono, A. | +2

3

Comparison of outcomes after plasma therapy or eculizumab in pediatric patients with atypical hemolytic uremic syndrome

enthalten in: Clinical and experimental nephrology | 2022

von Ashida, A. | Matsumura, H. | Shimono, A. | +2

4

Comparison of outcomes after plasma therapy or eculizumab in pediatric patients with atypical hemolytic uremic syndrome

enthalten in: Clinical and experimental nephrology | 2022

von Ashida, A. | Matsumura, H. | Shimono, A. | +2

5

Case Report : Successful Treatment With Anti-C5 Monoclonal Antibody in a Japanese Adolescent Who Developed Thrombotic Microangiopathy After Autologous Bone Marrow Transplantation for Malignant Lymphoma

enthalten in: Frontiers in pediatrics | 2022

von Shimizu, S. | Morohashi, T. | Kanezawa, K. | +3

6

Case Report: Successful Treatment With Anti-C5 Monoclonal Antibody in a Japanese Adolescent Who Developed Thrombotic Microangiopathy After Autologous Bone Marrow Transplantation for Malignant Lymphoma

in: Frontiers in Pediatrics | 2022

von Shoichi Shimizu | Tamaki Morohashi | Koji Kanezawa | +3

7

Detection of Neisseria meningitidis in a patient receiving ravulizumab by the FilmArray® Meningitis/Encephalitis panel- A case report

enthalten in: The Journal of infection | 2021

von Navarro-Carrera, P. | García-Rodríguez, J. | Cendejas-Bueno, E.

CommentIn: J Infect. 2022 Jun;84(6):834-872. - PMID 35346732

8

Eculizumab as a New Treatment for Severe Acute Post-infectious Glomerulonephritis : Two Case Reports

enthalten in: Frontiers in medicine | 2021

von Chehade, H. | Guzzo, G. | Cachat, F. | +8

9

Eculizumab as a New Treatment for Severe Acute Post-infectious Glomerulonephritis: Two Case Reports

in: Frontiers in Medicine | 2021

von Hassib Chehade | Gabriella Guzzo | Gabriella Guzzo | +10

10

Cost burden of breakthrough hemolysis in patients with paroxysmal nocturnal hemoglobinuria receiving ravulizumab versus eculizumab

enthalten in: Hematology (Amsterdam, Netherlands) | 2020

von Tomazos, I. | Sierra, J. | Johnston, K. | +3